PD53-07 CLINICAL SIGNIFICANCE OF THE SIAα2,3GAL-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN ASSAY FOR PROSTATE CANCER DETECTION

Tohru Yoneyama,Yuki Tobisawa,Tomokazu Ishikawa,Shingo Hatakeyama,Kazuyuki Mori,Mihoko Sutoh Yoneyama,Teppei Okubo,Koji Mitsuzuka,Wilhelmina C.M. Duivenvoorden,Jehonathan H. Pinthus,Yasuhiro Hashimoto,Akihiro Ito,Takuya Koie,Mutsuhiro Date,Robert A. Gardiner,Chikara Ohyama

PD53-07 CLINICAL SIGNIFICANCE OF THE SIAα2,3GAL-GLYCOSYLATED PROSTATE-SPECIFIC ANTIGEN ASSAY FOR PROSTATE CANCER DETECTION

2020

Tohru Yoneyama
Yuki Tobisawa
Tomokazu Ishikawa
Shingo Hatakeyama
Kazuyuki Mori
Mihoko Sutoh Yoneyama
Teppei Okubo
Koji Mitsuzuka
Wilhelmina C.M. Duivenvoorden
Jehonathan H. Pinthus
Yasuhiro Hashimoto
Akihiro Ito
Takuya Koie
Mutsuhiro Date
Robert A. Gardiner
Chikara Ohyama

INTRODUCTION AND OBJECTIVE:To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify significant prostate cancer (sigPC) we determined the performance of LacdiNAc-...

Keywords:

Clinical significance
Internal medicine
Oncology
Pathology
Medicine
Prostate Specific Antigen Assay
Prostate cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations